156 related articles for article (PubMed ID: 17170375)
1. Pravastatin enhances beneficial effects of olmesartan on vascular injury of salt-sensitive hypertensive rats, via pleiotropic effects.
Yamamoto E; Yamashita T; Tanaka T; Kataoka K; Tokutomi Y; Lai ZF; Dong YF; Matsuba S; Ogawa H; Kim-Mitsuyama S
Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):556-63. PubMed ID: 17170375
[TBL] [Abstract][Full Text] [Related]
2. Novel mechanism and role of angiotensin II induced vascular endothelial injury in hypertensive diastolic heart failure.
Yamamoto E; Kataoka K; Shintaku H; Yamashita T; Tokutomi Y; Dong YF; Matsuba S; Ichijo H; Ogawa H; Kim-Mitsuyama S
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2569-75. PubMed ID: 17932313
[TBL] [Abstract][Full Text] [Related]
3. Effects of olmesartan on Apelin/APJ and Akt/endothelial nitric oxide synthase pathway in Dahl rats with end-stage heart failure.
Fukushima H; Kobayashi N; Takeshima H; Koguchi W; Ishimitsu T
J Cardiovasc Pharmacol; 2010 Jan; 55(1):83-8. PubMed ID: 19904215
[TBL] [Abstract][Full Text] [Related]
4. Effects of combined olmesartan and pravastatin on glucose intolerance and cardiovascular remodeling in a metabolic-syndrome model.
Mizukawa M; Ohmori K; Obayashi A; Ishihara Y; Yoshida J; Noma T; Yukiiri K; Kosaka H; Kohno M
Hypertens Res; 2009 Jul; 32(7):617-24. PubMed ID: 19461650
[TBL] [Abstract][Full Text] [Related]
5. Effect of olmesartan and pravastatin on experimental cerebral aneurysms in rats.
Kimura N; Shimizu H; Eldawoody H; Nakayama T; Saito A; Tominaga T; Takahashi A
Brain Res; 2010 Mar; 1322():144-52. PubMed ID: 20114040
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of balloon injury-induced neointimal formation by olmesartan and pravastatin in rats with insulin resistance.
Chen M; Ichiki T; Ohtsubo H; Imayama I; Inanaga K; Miyazaki R; Sunagawa K
Hypertens Res; 2007 Oct; 30(10):971-8. PubMed ID: 18049030
[TBL] [Abstract][Full Text] [Related]
7. Renoprotective effect of pravastatin in salt-loaded Dahl salt-sensitive rats.
Kido M; Ando K; Oba S; Fujita T
Hypertens Res; 2005 Dec; 28(12):1009-15. PubMed ID: 16671341
[TBL] [Abstract][Full Text] [Related]
8. Improvement of glucose intolerance by combination of pravastatin and olmesartan in type II diabetic KK-A(y) mice.
Kanno H; Iwai M; Inaba S; Senba I; Nakaoka H; Sone H; Mogi M; Horiuchi M
Hypertens Res; 2009 Aug; 32(8):706-11. PubMed ID: 19478815
[TBL] [Abstract][Full Text] [Related]
9. Circulating angiopoietin-2 in essential hypertension: relation to atherosclerosis, vascular inflammation, and treatment with olmesartan/pravastatin.
David S; Kümpers P; Lukasz A; Kielstein JT; Haller H; Fliser D
J Hypertens; 2009 Aug; 27(8):1641-7. PubMed ID: 19390459
[TBL] [Abstract][Full Text] [Related]
10. Prepubertal angiotensin blockade exerts long-term therapeutic effect through sustained ATRAP activation in salt-sensitive hypertensive rats.
Dejima T; Tamura K; Wakui H; Maeda A; Ohsawa M; Kanaoka T; Haku S; Kengo A; Masuda S; Shigenaga A; Azuma K; Matsuda M; Yabana M; Hirose T; Uchino K; Kimura K; Nagashima Y; Umemura S
J Hypertens; 2011 Oct; 29(10):1919-29. PubMed ID: 21844822
[TBL] [Abstract][Full Text] [Related]
11. Simvastatin and losartan enhance nitric oxide and reduce oxidative stress in salt-induced hypertension.
Bayorh MA; Ganafa AA; Eatman D; Walton M; Feuerstein GZ
Am J Hypertens; 2005 Nov; 18(11):1496-502. PubMed ID: 16280288
[TBL] [Abstract][Full Text] [Related]
12. Pravastatin and olmesartan synergistically ameliorate renal failure-induced vascular calcification.
Iijima K; Ito Y; Son BK; Akishita M; Ouchi Y
J Atheroscler Thromb; 2014; 21(9):917-29. PubMed ID: 24834982
[TBL] [Abstract][Full Text] [Related]
13. Eplerenone potentiates protective effects of amlodipine against cardiovascular injury in salt-sensitive hypertensive rats.
Nakamura T; Fukuda M; Kataoka K; Nako H; Tokutomi Y; Dong YF; Yamamoto E; Yasuda O; Ogawa H; Kim-Mitsuyama S
Hypertens Res; 2011 Jul; 34(7):817-24. PubMed ID: 21471977
[TBL] [Abstract][Full Text] [Related]
14. An angiotensin II type 1 receptor blocker can preserve endothelial function and attenuate brain ischemic damage in spontaneously hypertensive rats.
Oyama N; Yagita Y; Sasaki T; Omura-Matsuoka E; Terasaki Y; Sugiyama Y; Sakoda S; Kitagawa K
J Neurosci Res; 2010 Oct; 88(13):2889-98. PubMed ID: 20544833
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic effects of angiotensin II type 1 receptor blocker at an advanced stage of hypertensive diastolic heart failure.
Nishio M; Sakata Y; Mano T; Yoshida J; Ohtani T; Takeda Y; Miwa T; Masuyama T; Yamamoto K; Hori M
J Hypertens; 2007 Feb; 25(2):455-61. PubMed ID: 17211254
[TBL] [Abstract][Full Text] [Related]
16. Additive effects of combined blockade of AT1 receptor and HMG-CoA reductase on left ventricular remodeling in infarcted rats.
Lee TM; Lin MS; Chou TF; Chang NC
Am J Physiol Heart Circ Physiol; 2006 Sep; 291(3):H1281-9. PubMed ID: 16565312
[TBL] [Abstract][Full Text] [Related]
17. Cardioprotective effect of angiotensin II type 1 receptor antagonist associated with bradykinin-endothelial nitric oxide synthase and oxidative stress in Dahl salt-sensitive hypertensive rats.
Yoshida K; Kobayashi N; Ohno T; Fukushima H; Matsuoka H
J Hypertens; 2007 Aug; 25(8):1633-42. PubMed ID: 17620960
[TBL] [Abstract][Full Text] [Related]
18. Atorvastatin prevents end-organ injury in salt-sensitive hypertension: role of eNOS and oxidant stress.
Zhou MS; Jaimes EA; Raij L
Hypertension; 2004 Aug; 44(2):186-90. PubMed ID: 15238570
[TBL] [Abstract][Full Text] [Related]
19. Olmesartan, but not amlodipine, improves endothelium-dependent coronary dilation in hypertensive patients.
Naya M; Tsukamoto T; Morita K; Katoh C; Furumoto T; Fujii S; Tamaki N; Tsutsui H
J Am Coll Cardiol; 2007 Sep; 50(12):1144-9. PubMed ID: 17868805
[TBL] [Abstract][Full Text] [Related]
20. Thiazide diuretics, endothelial function, and vascular oxidative stress.
Zhou MS; Schulman IH; Jaimes EA; Raij L
J Hypertens; 2008 Mar; 26(3):494-500. PubMed ID: 18300860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]